Economy
UMC Q2 net income surges 161%, but EPS misses estimates
The chipmaker's revenue exceeded expectations, while its stock remains well off highs amid tough sentiment.
US initial jobless claims rise to 197,000, below expectations
Weekly claims increased by 9,000 but remained lower than economists' forecast of 201,000.
CTS Q2 earnings report shows revenue and EPS growth; full-year guidance raised
The sensor and components maker reported 7% revenue growth to $144.8 million and adjusted EPS of $0.74.
Teradyne Profit Surges on Semiconductor Testing Demand
According to the Columbia Seligman Global Technology Fund, the company's shares have risen sharply over the past year, driven by improving industry sentiment and expectations for a recovery in test spending.
Bank of England holds interest rates at 3.75% as inflation risks rise
Three policymakers voted for a rate increase; energy prices and conflict in the Middle East cloud the outlook.
Arkema Reports Q2 Sales Growth with Improved EBITDA Margin
The French chemical company exceeded expectations in its second-quarter results, with shares rising 6.2% after the earnings call.
Hermès and Kering stocks diverge by record margin after earnings
Fresh reports underscore contrasting fortunes for the two French luxury giants.
Eni Doubles Q2 Profit, Boosts 2026 Buyback Program to $3.9 Billion
The Italian energy giant raises production guidance and accelerates share repurchases amid higher oil prices and output growth.
Black Cat Syndicate reports record cash flow in Q4 2026
The company held an earnings call for the period, according to a single source.
EssilorLuxottica Shares Rise on Outlook Confidence Despite Mixed Results
Investors focus on growth opportunities as the eyewear giant navigates a trade-off with profitability.
IQVIA reports Q2 2026 financial results and updates revenue guidance
The contract research organization reported accelerating organic growth and highlighted AI-driven gains in drug development and client contracts.
Eli Lilly and Resilience to Invest $750 Million in US Drug Manufacturing
The partnership aims to expand domestic production capacity and create hundreds of jobs, as tariff pressures mount.
Boston Scientific Q2 Revenue Hits $5.4B, Restructuring Announced
The company cut its full-year outlook and unveiled a global plan to reduce annual costs by $500 million.
Bitcoin Clears $64,000 Ahead of Fed Decision
Traders are split on rate outcome as crypto market shows mixed moves with key resistance and support levels in focus.
FDA raises concerns over skin cancer drug
Regulator questions data sufficiency and trial design for the third attempt at approval of RP1 treatment.
Kerry Reports Volume Growth Above Estimates in First Half
The company also discussed margin expansion and its 2030 financial targets in its half-year results.
Topaz Energy Q2 2026: Record liquids royalties, 80% FCF margin, raised guidance
The Canadian royalty company reported higher production, cash flow, and dividends while completing a C$38.7 million acreage acquisition.
Boston Scientific to cut jobs in global restructuring by 2029
The plan, costing up to $800 million, aims to save $500 million annually in pre-tax expenses.
Danone posts stronger Q2 2026 growth as margins improve
The French food company reported accelerated sales growth and better profitability in the second quarter of 2026.
Korean Air cargo growth driven by AI shipments
High-value semiconductors and server equipment reshape air cargo routes, with Southeast Asia gaining production share and Turkey eyeing transit opportunities.
Celestica Q2 Revenue Surges 62%
The electronics manufacturer raised its guidance, and Stifel lifted its price target to $500.
Zurn Elkay beats Q2 2026 estimates, raises outlook
The company exceeded analyst expectations for the quarter and increased its full-year guidance.
Werner Q2 2026: One-Way Revenue Per Truck Surges, Margins Improve
Truckload carrier reports highest revenue per truck growth in a decade, driven by capacity tightening and acquisition benefits.
TransUnion Beats Q2 Expectations, Raises Full-Year Outlook
The credit reporting agency posted adjusted EPS of $1.23 on revenue of $1.31 billion, both above analyst estimates.
Mineral Resources posts record FY 2026 results on stronger volumes
The Australian mining company achieved a new financial milestone for the fiscal year ending June 30, 2026.
Braveheart Bio targets up to $318.8M in US IPO
The clinical-stage biopharmaceutical firm backed by a16z aims to raise up to $318.8 million in its initial public offering, according to company filings.
Ariston Stock Crashes Despite Strong Q2 2026 Growth
The energy company's shares fell sharply even as its second-quarter results showed robust financial performance.
AMD Stock Slips Below 50-Day Moving Average Amid AI Bubble Fears
Chipmaker's shares decline in a sector-wide selloff, with earnings due August 4 and a new partnership with Anthropic.
Recordati Reports Q2 2026 Results with Rare Disease-Led Growth
The Italian pharmaceutical company saw a 17% increase in revenue from rare diseases and expanded margins in the first half of 2026.
Wall Street Files for SpaceX-Linked Products as Stock Sinks Over 40%
At least five financial institutions have applied to launch structured products with downside protection following SpaceX's post-IPO decline.